Table 1.
Demographic and clinical characteristics.
| Variables | No pregnancy | Pregnancy | Total | P value | |
| Patient, n (%) | 14 (56) | 11 (44) | 25 (100) | N/Aa | |
| Initial disease, n (%) | |||||
|
|
Hodgkin lymphoma | 11 (79) | 6 (55) | 17 (68) | N/A |
|
|
Non-Hodgkin lymphoma | 1 (7) | 2 (18) | 3 (12) | N/A |
|
|
Ewing sarcoma | 0 (0) | 1 (9) | 1 (4) | N/A |
|
|
Periarteritis nodosa | 0 (0) | 1 (9) | 1 (4) | N/A |
|
|
Systemic mastocytosis | 1 (7) | 0 (0) | 1 (4) | N/A |
|
|
Sickle cell disease | 0 (0) | 1 (9) | 1 (4) | N/A |
|
|
Neurolupus | 1 (7) | 0 (0) | 1 (4) | N/A |
| Gonadotoxic treatment before ovarian tissue cryopreservation, n (%) | 12 (67) | 6 (33) | 18 (100) | .99 | |
| Age at cryopreservation (years), mean (SD) | 26.2 (4.6) | 26.7 (3.8) | 26.4 (4.2) | .89 | |
| Age at transplantation (years), mean (SD) | 33.6 (3.9) | 31.6 (4.9) | 32.8 (4.3) | .81 | |
| Storage duration (years), mean (SD) | 6.7 (2.5) | 5.9 (3.2) | 6.4 (2.8) | .29 | |
| Number of grafted fragments, mean (SD) | 13 (2.6) | 11.6 (4.6) | 12 (3) | .56 | |
| Follicular density/mm2, mean (SD) | 4.9 (5.2) | 5 (5.1) | 5 (4.7) | .97 | |
| Time to conception (months), mean (SD) | N/A | 11.3 (6.3) | N/A | N/A | |
| Follicle-stimulating hormone levels (mUI/mL), mean (SD) | 79 (24.8) | 86.9 (30.4) | 82.5 (27.1) | .43 | |
| Anti-Müllerian hormone levels (ng/mL), mean (SD) | 0.08 (0.15) | 0.03 (0.09) | 0.06 (0.13) | .52 | |
| Age at conception, mean (SD) | N/A | 33.9 (5.2) | N/A | N/A | |
| Live births, n | N/A | 14 | 14 | N/A | |
aN/A: not available.